five lipid chains have ~100 fold less activity, and those with four lose agonistic activity. Core region of LPS is divided into the inner core and the outer core. The former part is linked to the lipid and the latter is connected to the O-specific chain. The 6' position of lipid A is glycosylated with eight-carbon sugar, 3-deoxy-D-manno-octulosonic acid (KDO). Found in most endotoxins, KDO is believed to be a potential target of therapy against LPS-associated diseases. Other core sugars include L-glycero-D-manno-heptose, glucose, galactose, and N-acetylglucosamine.
. The Gram-negative bacterial envelope is composed of two bacterial membranes, outer and inner membrane. The outer membrane is enriched with lipopolysaccharide (LPS), which is an identifying feature of Gram-negative bacteria such as Escherichia coli. The lipid portion of the outer layer of the outer membrane is exclusively composed of LPS molecules. A single E. coli cell possesses approximately 2 million LPS molecules.
Fig. 2.
Chemical structure of the lipopolysaccharide (LPS) is presented. LPS consists of a polysaccharide, or long chain of sugar, and lipid A. The polysaccharide varies depending on bacterial species and is composed of O-specific chain (O-antigen) and two-part cores (Outer core and Inner core). Lipid A virtually includes two glucosamine sugars modified by phosphate and a variable number of fatty acids. It also has negatively charged phosphate groups. perfusion, multi-organ failure, and death observed in septic shock. [4] [5] [6] 
GENETIC REGULATION OF LPS RESPONSE
Decreased sensitivity to the proinflammatory and lethal effects of LPS were observed in the C3H/HeJ mouse strain.
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C3H/HeJ mice were naturally resistant to LPS preparations from Salmonella typhosa 0-901 and Escherichia coli 0127:B8, tolerating 20 and 38 times the medial lethal dose, respectively, for other C3H sublines that are normally responsive to LPS. In addition, LPS or Lipid A is not cytotoxic in vitro for macrophages from C3H/HeJ, but directly cytotoxic for those from LPS-responsive mice. 10 It was also suggested that B lymphocytes from C3H/HeJ mice were specifically hyporesponsive to LPS, but responded normally to other B-cell stimulators. 11 LPS responses were also defective in T lymphocytes and fibroblasts from C3H/HeJ mice. 12 These results indicated that C3H/HeJ mice were hyporesponsive to LPS. Genetically, it was demonstrated that these LPS hyporesponsive mouse strains have a defective Lps al- 
SIGNAL TRANSDUCTION OF TLRs
TLR proteins are ligand-stimulated receptor molecules that elicit their pleiotropic effects through activation of the transcription factors nuclear factor kappaB (NFκ B) and activator protein-1 (AP-1). Given that the cytoplasmic domain of TLR proteins is homologous to that of IL-1R, these regions are referred to as Toll/IL-1R (TIR) domain. Thus, the investigation of the cellular mechanism from TLR activation was www.irjournal.org approached on the basis of understanding IL-1R signaling pathway. When microbial products encounter their specific TLRs, TLRs recruit a single or a combination of adaptor molecule(s) containing TIR domain to its cytoplasmic TIR domain. At least four adaptors such as myeloid differentiation factor 88 (MyD88), MyD88 adaptor-like/TIR domaincontaining adaptor protein (Mal/TIRAP), TIR domaincontaining adaptor-inducing IFN-β (TRIF), and TRIF-related adaptor molecule (TRAM) have been identified in TLR-mediated signaling pathways. After binding to the cytoplasmic TIR domain of TLRs, these adaptor molecules associate with IL-1R-associated kinases (IRAKs) to mediate the signaling to a member of tumor necrosis factor receptor-associated factor (TRAF) family (e.g. TRAF6). Thereby, TLR-induced signaling leads to activation of IKKs and MAPKs to activate transcription factors such as NFκ B, AP-1, and interferon-regulatory factors, followed by inducing a pleiotropic gene expression involved in immune and inflammatory responses.
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SIGNALING CASCADE INDUCED BY LPS-TLR4 ENGAGEMENT
LPS interacts with LBP to form LPS-LBP complex which binds to CD14. However, CD14 can not mediate LPS signaling through the cell membrane, because CD14 does not have a transmembrane domain. Thus, it is believed that CD14 functions as the co-receptor for TLR4. 18 Furthermore, LPS/LBP/CD14 complex interacts with TLR4. LPS responses mediated through TLR4 require the presence of MD2, a cell surface protein. All these components form the complex of LPS/LBP/CD14/MD2/TLR4. 19 Upon the interaction of LPS with TLR4 and associated receptor components, TLR4 exploits the combination of Mal/TIRAP and MyD88 at the plasma membrane to induce inflammatory gene expression (called MyD88-dependent pathway). In parallel, TLR4 is internalized to endosome by the interaction with TRAM, followed by a subsequent interaction with TRIF, leading to the transcription factor activation of interferon-regulatory factors which is responsible for type-I interferon (Interferon-α /β ) production (termed MyD88-independent or TRIFdependent pathway). [20] [21] [22] MyD88-dependent pathways are generally involved in regulating inflammatory responses and innate immunity and subsequent adaptive immunity, while MyD88-independent pathways are assigned to anti-viral activity due to the involvement of Interferon-α /β production. Given that TLR4 activation induces the signaling pathways involved in inflammatory responses, innate and adaptive immunity, and anti-viral activity, engagement of TLR4 with LPS broadly impacts a wide range of human diseases including inflammatory diseases to infectious diseases.
INNATE IMMUNITY AND BIOLOGICAL SIGNI-FICANCE OF TLRs
The activation of TLRs induces the innate immunity which is an earlier evolutionary form of host defense and serves the secondary immune system by stimulating and orienting the adaptive immune responses. Indeed, mammalian TLR activation leads to expression and release of a plethora of cytokines, such as interleukins. These cytokines play direct or indirect role in adaptive immune system. It is clear that disruptions in innate immunity predispose human to microbial infections as described in the following examples. In the severely burned patient, the disruption of skin as not merely a barrier, but an organ adorned with antimicrobial peptides and first-line effecter cells like macrophages, poses great risks to microbial infections. In patients with cystic fibrosis, the alterations in salinity of the bronchial airway fluid appear to disable the function of antimicrobial peptides that are found in the respiratory epithelium, thereby leading to colonization and infection with organisms like Staphyloccoci and Pseudomonas. 23, 24 In the Drosophila , TOLL (Drosophila ortholog of mammalian TLR) participates in dorsal-ventral development. But in adult flies, TOLL induces the antifungal peptide, drosomycin, which is mediated through the activation of a transcription factor Dorsal. 25 In comparison with TOLL, 18-wheeler causes the expression of the anti-bacterial peptide, attacin, through the activation of Dorsal-related immunity factor (DIF). While Dorsal and DIF are Drosophila NFκ B proteins, Dorsal is selectively activated by TOLL and DIF is specifically activated by18-wheeler. 25, 26 Hundreds of anti-bacterial peptides have been reported to participate in innate immunity, not only of insects, but also of all multi-cellular organisms including human and plants. Among a wide variety of anti-microbial peptide, defensins are the representative with a wide spectra of anti-bacterial activity directed against various bacteria, fungi, and enveloped viruses. 27 Although the molecular mechanisms are not fully understood, they may involve the transient appearance of channel-like structures. Defensins and most other anti-microbial peptides act by permeabilizing the cell membranes of microorganisms, resulting in the efflux of solutes. Defensins are major constituents of the microbicidal granules of blood granulocytes and are also abundantly expressed in intestinal epithelial cells specialized for host defense func-www.irjournal.org tions. A constitutively expressed human epithelial α -defensin is abundant in the kidney and the urogenital tract, and an infection-or cytokine-inducible β -defensin is abundant in the skin. In addition to defensins, mammals produce cathelicidins which are a group of myeloid antimicrobial peptides. 28 In addition, the complement cascade plays one of the major roles in mammalian innate immunity. It is activated either directly or indirectly by microorganisms and leads to the phagocytosis through opsonization or the assembly of a pore-forming membrane attack complex on the surface of microorganism.
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IMPACTS OF LPS-TLR4 ENGAGEMENT IN THE GASTROINTESTINAL TRACT
LPS is the major constituent of the outer membrane of Gram-negative bacteria and specifically stimulates TLR4, resulting in the production of pleiotropic cytokines/chemokines. Given that the human colon harbors a large collection of commensal bacteria, the colonic lumen functions as a reservoir of LPS released from Gram-negative bacteria therein. Indeed, approximately 50 μ g/mL of LPS could be observed in the human colon. 30, 31 The composition of intestinal microbes varies among individuals, depending on individual life conditions such as life stages, regimen, environment, genetic factors, and etc. Nevertheless, a well-orchestrated balance between Gramnegative and Gram-positive bacteria is maintained in the healthy human gut with a predominance of Gram-positive bacteria. 32 Gram-negative bacteria, however, are suggested to be considerably increased in IBD patients [33] [34] [35] and accumulated at high concentrations in an inflamed lesion of the intestine. 36 Increased Gram-negative bacteria in the gut are able to increase the luminal amount of LPS, which consequently makes a strong effect on the development and perpetuation of intestinal inflammation. In line with this, our recent study demonstrated that increased LPS level in the colon resulted in the intestinal inflammation. 37 Furthermore, it is worth noting that the expression of TLR4 was suggested to be increased in IBD patients. 38 As a confirmatory study of this observation, the treatment of TLR4 antagonist was able to ameliorate mouse experimental colitis. 39 Meanwhile, LPS was also suggested to work as a critical pathogenic factor inducing necrotizing enterocolitis. 30 Together, these studies suggested that TLR4 activation by LPS should be an important pathogenic element related to the development and perpetuation of intestinal inflammatory diseases. On the other hand, LPS was suggested to play a protective effect in a mouse epithelial injury model. 40 Furthermore, LPS normally present in the gut is believed to be harmless, because the normal intestinal epithelium constantly exposed with gut microbiota might be tolerant to LPS. 41, 42 Although beneficial effects of gut LPS were suggested using animal experimental models, a growing body of evidence indicates that LPS in the intestine has a potency to promote the intestinal inflammation.
